« Cell Therapeutics gets FDA OK for production site - BusinessWeek
ImmunoGen cancer drug gets ‘orphan drug’ status - The Associated Press »

Clinical Setback Forces Restructuring At XenoPort - Wall Street Journal

Published by Google Inc. March 8th, 2010 in Google FDA News, Regulatory Affairs

Search